Open this publication in new window or tab >>Show others...
2022 (English)In: ACS Medicinal Chemistry Letters, E-ISSN 1948-5875, Vol. 13, no 2, p. 257-261Article in journal (Refereed) Published
Abstract [en]
Carbapenem resistance caused by metallo-β-lactamases is a serious global challenge that, if not tackled efficiently, is expected to lead to millions of deaths in the coming decades. Verona-integron encoded metallo-β-lactamase 2 (VIM-2) is a bacterial enzyme that has been reported from multidrug-resistant nosocomial isolates of Pseudomonas aeruginosa and other Gram-negative pathogens. As it hydrolyzes most β-lactams efficiently, including carbapenems, it is a major threat to current antimicrobial chemotherapies. So far, there is no clinically applicable inhibitor for this enzyme. In this work, the backbone NMR resonance assignment of VIM-2 is disclosed, opening up NMR investigations of this clinically important enzyme and its potential inhibitors for solutions, enabling a rational improvement of inhibitor candidates. Making use of the assignment, we identified the active enantiomer of a VIM-2 inhibitor candidate as well as its possible binding site and Kd, utilizing NMR chemical shift titration experiments.
Place, publisher, year, edition, pages
American Chemical Society (ACS)American Chemical Society (ACS), 2022
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:uu:diva-469424 (URN)10.1021/acsmedchemlett.1c00635 (DOI)000755513000020 ()
Funder
Swedish Research Council, 2013-8804Swedish Research Council, 2020-03431
2022-03-102022-03-102025-02-20Bibliographically approved